Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3635334012 | Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3636381018 | Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3636382013 | Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4778981000172115 | therapiegerelateerde AML door en na toediening van oncolyticum | nl | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 4778991000172117 | therapiegerelateerde AML door en na toediening van cytostaticum | nl | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 4779001000172117 | therapiegerelateerde acute myeloïde leukemie door en na toediening van antineoplastisch middel | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Due to | Administration of antineoplastic agent | true | Inferred relationship | Some | 1 | |
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | affection liée à une drogue et/ou un médicament | false | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Complication of procedure | false | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | séquelle | false | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Complication of chemotherapy (disorder) | true | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) | false | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | After | Administration of antineoplastic agent | true | Inferred relationship | Some | 2 | |
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Associated morphology | therapiegerelateerde AML en MDS | false | Inferred relationship | Some | 3 | |
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Causative agent | Antineoplastic agent (substance) | true | Inferred relationship | Some | 3 | |
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Finding site | Bone marrow structure | true | Inferred relationship | Some | 3 | |
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Disorder following clinical procedure | false | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Complication of introduction procedure | true | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Drug-induced lesion | true | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Hematologic complication of procedure | true | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Neoplastic complication of procedure | true | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Is a | Therapy-related myelodysplastic syndrome (disorder) | true | Inferred relationship | Some | ||
| Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Associated morphology | Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | True | Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | Inferred relationship | Some |
This concept is not in any reference sets
FHIR